跳至主要内容
临床试验/JPRN-UMIN000005887
JPRN-UMIN000005887已完成2 期

Randomized phase II study of Valproic acid + weekly paclitaxel in unresectable advanced/recurrent gastric cancer - Phase II study of valproic acid + weekly paclitaxel in gastric cancer

Kanazawa University Hospital0 个研究点目标入组 66 人开始时间: 2011年8月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Pregnant women or women who like to be pregnant 2) History of allergy against Cremophol EL 3) Intestinal pneumonia, lung fibrosis, and severe COPD 4) Clinically important infection or acute inflammation 5) Psychological disease 6) Other severe complication or malignancy 7) CNS metastasis 8) Doctor's dicision not to be registered to this study

研究者

相似试验

招募中
1 期
Randomized phasE 2 study of Valproic acid in combination with bevacizumab and Oxaliplatin/fLUoropyrimidine regimens in patients with ras-mutated metastaTIc cOlorectal caNcerpatients with ras-mutated metastaTIc colorectal cancerMedDRA version: 20.0Level: LLTClassification code 10007446Term: Carcinoma of rectumSystem Organ Class: 100000004864
EUCTR2018-001414-15-ITISTITUTO NAZIONALE TUMORI - IRCCS FONDAZIONE PASCALE200
进行中(未招募)
1 期
RANDOMIZED PHASE II-STUDY ON VALPROIC ACID, ALL-TRANS RETINOIC ACID AND THEIR COMBINATION IN INDUCTION AND CONSOLIDATION THERAPY AS WELL AS PEGFILGRASTIM AFTER CONSOLIDATION THERAPY IN YOUNGER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
EUCTR2004-004321-95-ATniversity of Ulm304
已完成
1 期
Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal SubjectsHealthy
NCT01073059Chonbuk National University10
进行中(未招募)
不适用
A phase II study assessing the activity of valproate acid plus doxorubicin in refractory or recurrent malignant mesothelioma.This is a prospective phase II study investigating well-known antimetabolite (doxorubicin) and antiepileptic (valproate) drugs, in combination, for the treatment of refractory or recurrent malignant mesothelioma for which no active treatment is available in this indication.
EUCTR2006-001443-63-BEEuropean Lung Cancer Working Party41
进行中(未招募)
不适用
Preclinical and clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of head and neckRecurrent and/or metastatic squamous cell carcinoma of head and neckMedDRA version: 17.0Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2014-001523-69-ITIstituto Nazionale Tumori di Napoli - Fondazione G. Pascale39